Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-15 Purchase | 2024-10-17 4:19 pm | Upstream Bio Inc. | UPB | Chimovits Erez Director 10% Owner | 825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-17 4:17 pm | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-17 4:05 pm | Upstream Bio Inc. | UPB | AI Upstream LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 1,175,000 | $17 | $19,975,000 | 5,494,410 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-16 Option Award | 2024-12-17 4:18 pm | N/A 2034-12-15 | Upstream Bio Inc. | UPB | Ambrose Allison General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-10-15 Conversion | 2024-10-17 4:19 pm | N/A N/A | Upstream Bio Inc. | UPB | Chimovits Erez Director 10% Owner | 7,219,578 | $0 | 4,554,873 (Indirect) | View |
| 2024-10-15 Conversion | 2024-10-17 4:17 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 7,219,578 | $0 | 4,554,873 (Indirect) | View |
| 2024-10-15 Conversion | 2024-10-17 4:05 pm | N/A N/A | Upstream Bio Inc. | UPB | AI Upstream LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 4,319,410 | $0 | 5,494,410 (Direct) | View |
| 2024-10-15 Conversion | 2024-10-15 7:21 pm | N/A N/A | Upstream Bio Inc. | UPB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 1,747,673 | $0 | 894,733 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Chimovits Erez Director | 17,096 | $0 | 17,096 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Ruddy Marcella K. Director | 17,096 | $0 | 17,096 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Renaud Ronald C JR Director | 17,096 | $0 | 17,096 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Fleming Harold Edward Director | 17,096 | $0 | 17,096 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Beckman Daniella Director | 34,681 | $0 | 34,681 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Ratcliffe Liam Director | 17,096 | $0 | 17,096 (Direct) | View |
Ownership | 2024-10-10 8:48 pm | N/A N/A | Upstream Bio Inc. | UPB | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% Owner | 0 | $0 | 894,733 (Direct) | View |
Ownership | 2024-10-10 8:42 pm | N/A 2034-04-03 | Upstream Bio Inc. | UPB | Sutherland Everett Rand Chief Executive Officer | 0 | $0 | 1,920,503 (Direct) | View |
Ownership | 2024-10-10 8:33 pm | N/A N/A | Upstream Bio Inc. | UPB | Chimovits Erez Director 10% Owner | 0 | $0 | 4,868,589 (Indirect) | View |
Ownership | 2024-10-10 8:19 pm | N/A 2032-01-01 | Upstream Bio Inc. | UPB | Houghton Adam Chief Business Officer | 0 | $0 | 426,515 (Direct) | View |
Ownership | 2024-10-10 8:14 pm | N/A 2032-07-02 | Upstream Bio Inc. | UPB | Ruddy Marcella K. Director | 0 | $0 | 64,141 (Direct) | View |
Ownership | 2024-10-10 8:12 pm | N/A 2032-06-03 | Upstream Bio Inc. | UPB | Deykin Aaron Chief Medical Officer | 0 | $0 | 597,402 (Direct) | View |
Ownership | 2024-10-10 8:09 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 0 | $0 | 4,868,589 (Indirect) | View |
Ownership | 2024-10-10 8:09 pm | N/A 2032-01-01 | Upstream Bio Inc. | UPB | Renaud Ronald C JR Director | 0 | $0 | 426,401 (Direct) | View |
Ownership | 2024-10-10 8:09 pm | N/A 2034-03-26 | Upstream Bio Inc. | UPB | GRAY MICHAEL CFO and COO | 0 | $0 | 597,490 (Direct) | View |
Ownership | 2024-10-10 4:27 pm | N/A N/A | Upstream Bio Inc. | UPB | AI Upstream LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 0 | $0 | 4,117,646 (Direct) | View |